Physician profile
Leon Egozi
NPI 1780649293
$2,539.88
in general payments reported to CMS, 2019-2025
25 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $59.81 · 2021: $360 · 2022: $342 · 2023: $361 · 2024: $107 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $903.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $812.50 | 2019 | |
| Davol INC. | $566.46 | 2022-2025 | Phasix Mesh |
| Elucent Medical | $202.62 | 2023 | |
| Tela Bio, INC. | $195.50 | 2020-2024 | Ovitex 2s |
| Intuitive Surgical, INC. | $111.76 | 2021 | |
| Biotissue Holdings INC. | $85.55 | 2022 | |
| Baxter Healthcare | $52.09 | 2021-2025 | Perclot |
| Microline Surgical INC | $46.29 | 2022 | |
| Innocoll Pharmaceuticals Limited | $45.94 | 2021-2022 | |
| Hologic Sales and Service, LLC | $40.05 | 2023-2024 | Atec, Localizer |
| Teleflex LLC | $38.44 | 2019-2021 | |
| Molli Surgical (US) INC | $35.87 | 2024 | |
| Boston Scientific Corporation | $27.58 | 2022 | |
| Avanos Medical | $27.49 | 2021 | |
| Focal Therapeutics, INC. | $27.14 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $26.48 | 2025 | Veozah |
| Integra Lifesciences Corporation | $26.19 | 2022 | |
| Organogenesis INC. | $25.07 | 2022 | |
| Acera Surgical, INC. | $24.98 | 2022 | |
| Acell, INC. | $24.83 | 2019 | |
| Smith+Nephew, INC. | $24.25 | 2024 | Pico 14 |
| Acorda Therapeutics, INC | $20.92 | 2019 | |
| Kci USA, INC. | $20.05 | 2023 | Abthera, Prevena, V.A.C. Veraflo Cleanse Choice |
| Kerecis Limited | $17.97 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic USA, INC. | $13.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Egozi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.